Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
about
From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsReplicon RNA Viral Vectors as VaccinesPreventative and therapeutic vaccines for cervical cancer.Therapeutic Vaccine Strategies against Human Papillomavirus.Therapeutic and prophylactic applications of alphavirus vectors.Therapeutic vaccines against human papillomavirus and cervical cancer.Perspectives for the development of human papillomavirus vaccines and immunotherapy.Immunologic treatments for precancerous lesions and uterine cervical cancer.Oncolytic Alphaviruses in Cancer Immunotherapy.A Semliki forest virus vector engineered to express IFNα induces efficient elimination of established tumors.Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.Noninvasive monitoring of cancer therapy induced activated T cells using [18F]FB-IL-2 PET imaging.Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice.Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Therapeutic vaccines for high-risk HPV-associated diseases.
P2860
Q26865532-FDF05A8F-4E16-4F62-B63F-66FD60A991D4Q28076639-A096095D-C132-4024-B024-BBD2B9D0EEFCQ35623323-E200EEB8-AE95-48EB-B1F1-F5D1BD6439D1Q35826752-1F6DB015-8CD8-421E-81F2-416E3144266CQ37322650-CC71AB07-65C4-4F45-BEAD-9C67A1361FC4Q37418916-662EBDB2-9854-42D0-B003-5C72F5335D4AQ37658876-E8A4CAB0-1805-410B-9569-FC8230A09D7BQ37703113-75E22802-E0A7-40E1-8BD3-D1ADCF767CA4Q39247874-0E00FC6D-9B13-44F4-86AA-0177B7A4A58BQ39511476-1E1CFDBE-97A4-493F-8AE4-0FB422452D3DQ40306609-4FB24335-EDD7-4B50-A5B2-97B1092B3548Q40336066-E0E77489-2831-4172-A1F8-8CBCFE4487D1Q40515045-722E68BB-1D8C-43AA-805A-08B7968F1F9BQ45399754-F2BFFF49-2F4C-4FF4-A86F-490C6B67465EQ45477179-2280DAA9-B8B5-48BA-A0B1-396ACB69D06EQ45872770-3014400F-732F-4EBD-AF11-1FB56CB2883CQ47093975-AE7C7D63-5B4C-4EE6-BC0E-1819CA0B8785Q47255618-F0B7272B-C11B-4311-A3E4-A3334CAD2F2B
P2860
Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Eradication of established HPV ...... a fusion protein of E6 and E7.
@en
type
label
Eradication of established HPV ...... a fusion protein of E6 and E7.
@en
prefLabel
Eradication of established HPV ...... a fusion protein of E6 and E7.
@en
P2093
P921
P1433
P1476
Eradication of established HPV ...... a fusion protein of E6 and E7.
@en
P2093
Annelies Riezebos-Brilman
Bert Dontje
Joke Regts
Laura Bungener
P304
P356
10.1016/S0264-410X(02)00558-3
P407
P577
2003-03-01T00:00:00Z